文献速递流行病学与生物统计临床试验与 GCP

面向实用性临床试验的偏好知情整群随机设计

Preference-Informed Cluster Randomized Design for Pragmatic Clinical Trials.
PubMed 文献 · Stat Med · 2026-01-01

整群随机试验(CRT)在实用性试验中易受治疗不依从影响,尤其当整群偏好导致受试者偏离分配治疗时。该研究受一项川崎病多中心试验启发,提出偏好知情整群随机设计(PICRD)下的贝叶斯分层模型,将整群层面治疗转换纳入分析而非排除不依从整群;模拟显示PICRD在主要疗效上保持更高检验效能、95%可信区间更窄、偏倚与均方根误差更稳定,优于符合方案分析。

要点

  • PICRD贝叶斯分层模型将整群层面治疗转换纳入分析,而非排除不依从整群。
  • 模拟显示PICRD在主要疗效上保持更高检验效能,95%可信区间更窄。
  • PICRD在存在大量不依从时偏倚与均方根误差更稳定,优于符合方案分析。

核心结论

  • 在贝叶斯分层框架中显式建模偏好,PICRD为实用性场景下整群随机试验提供灵活稳健的解决方案,尤其当接受随机分配或依从随机化常不现实时。

研究设计与样本

  • 研究提出偏好知情整群随机设计(PICRD)下的贝叶斯分层模型,并通过模拟研究评估该模型在不同治疗效应量和转换比例下的性能。
  • 研究直接受一项计划中的多中心川崎病高危冠状动脉异常患者试验启发,该试验中机构治疗偏好影响参与意愿和依从性。

主要发现

  • 模拟结果显示,在存在大量不依从时,PICRD模型在主要治疗效应上保持更高检验效能,产生更窄的95%可信区间,且偏倚和均方根误差更稳定,一致优于符合方案分析。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cluster randomized trials (CRTs), in which entire clusters of subjects are randomized to treatment arms, are widely used in pragmatic trials to evaluate interventions under real-world conditions. However, CRTs are particularly vulnerable to treatment non-adherence, especially when cluster-level preferences lead subjects in clusters to deviate from their assigned treatment. Such deviations can reduce power, introduce bias, and compromise generalizability if not properly addressed. This research is directly motivated by a planned multi-center trial in Kawasaki Disease patients with high risk for coronary artery abnormalities, in which institutional treatment preferences influence both willingness to participate and adhere. To address this issue, we propose a Bayesian hierarchical model under a Preference-Informed Cluster Randomized Design (PICRD). This model explicitly incorporates cluster-level treatment switching into the analysis rather than excluding non-willing or non-adherent clusters. We conduct a simulation study to evaluate the performance of the PICRD model across a range of treatment effect sizes and switching proportions. Results demonstrate that the PICRD model consistently outperforms per-protocol analyses by maintaining higher power for the main treatment effect, producing narrower 95% credible intervals, and yielding more stable bias and root mean square error in the presence of substantial non-adherence. By explicitly modeling preference within a Bayesian hierarchical framework, the PICRD approach provides a flexible and robust solution for CRTs conducted in pragmatic settings when willingness to accept randomization assignment or adherence to randomization is often unrealistic.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Cheng Y, Tremoulet A, Jain S, et al. Preference-Informed Cluster Randomized Design for Pragmatic Clinical Trials. Stat Med. 2026. PMID: 41641863. doi:10.1002/sim.70426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。